Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 184 results for: GCaMP6f

Clear keywords
Showing: 161 - 180 of 184 results

  2. pAAV-S5E2-GCaMP6f (AAV PHP.eB)

    Viral Prep
    #135632-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-GCaMP6f (#135632). In addition to the viral particles, you will also receive purified pAAV-S5E2-GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Available Since
    Sept. 13, 2021
    Availability
    Academic Institutions and Nonprofits only

  3. pAAV-Ef1a-Con/Foff 2.0-GCaMP6F (AAV8)

    Viral Prep
    #137123-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-Ef1a-Con/Foff 2.0-GCaMP6F (#137123). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Con/Foff 2.0-GCaMP6F plasmid DNA. EF1a-driven, Cre-dependent expression of GCaMP6f (inhibited in presence of Flp). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth, INTRSECT 2.0 Project
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    EF1a
    Available Since
    May 5, 2021
    Availability
    Academic Institutions and Nonprofits only

  4. pAAV-mDlx-GCaMP6f-Fishell-2 (AAV Retrograde)

    Viral Prep
    #83899-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-mDlx-GCaMP6f-Fishell-2 (#83899). In addition to the viral particles, you will also receive purified pAAV-mDlx-GCaMP6f-Fishell-2 plasmid DNA. mDlx-driven expression of GCaMP6f. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/
    Promoter
    mDlx
    Available Since
    June 1, 2020
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV.CAG.GCaMP6f.WPRE.SV40 (AAV2)

    Viral Prep
    #100836-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV.CAG.GCaMP6f.WPRE.SV40 (#100836). In addition to the viral particles, you will also receive purified pAAV.CAG.GCaMP6f.WPRE.SV40 plasmid DNA. CAG-driven GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Douglas Kim, GENIE Project
    Article
    Chen et al Nature. 2013 Jul 18;499(7458):295-300. d
    Promoter
    CAG
    Available Since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only

  7. pAAV-TRE-GCaMP6s

    Plasmid
    #135418
    Purpose
    Can be used to drive amplified GCaMP6s expression when combined with TET driver . Can be used to create adeno-associated virus to express TET-driven GCaMP6s.
    Depositor
    Rylan Larsen
    Insert
    GCaMP6s
    Use
    AAV
    Expression
    Mammalian
    Promoter
    TRE
    Available Since
    Feb. 3, 2020
    Availability
    Academic Institutions and Nonprofits only
    135418-plasmid-map-sequence-id-270731

    Enlarge

  8. pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 (AAV2)

    Viral Prep
    #100835-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 (#100835). In addition to the viral particles, you will also receive purified pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 plasmid DNA. CAG-driven, Cre-dependent GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Douglas Kim, GENIE Project
    Article
    Chen et al Nature. 2013 Jul 18;499(7458):295-300. d
    Promoter
    CAG
    Available Since
    July 8, 2020
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV_BiPVe3_GCaMP6f (AAV1)

    Viral Prep
    #213943-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiPVe3_GCaMP6f (#213943). In addition to the viral particles, you will also receive purified pAAV_BiPVe3_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the PV+ basket cell-targeting enhancer E3. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV_BiVIPe4_GCaMP6f (AAV1)

    Viral Prep
    #213859-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiVIPe4_GCaMP6f (#213859). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the VIP interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV_BiSSTe10_GCaMP6f (AAV1)

    Viral Prep
    #213818-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiSSTe10_GCaMP6f (#213818). In addition to the viral particles, you will also receive purified pAAV_BiSSTe10_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E10. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV_BiCHATe27_GCaMP6f (AAV5)

    Viral Prep
    #213833-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV_BiSSTe4_GCaMP6f (AAV1)

    Viral Prep
    #213947-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiSSTe4_GCaMP6f (#213947). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV_BiPVe4_GCaMP6f (AAV1)

    Viral Prep
    #213939-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV_BiPVe3_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213943-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe3_GCaMP6f (#213943). In addition to the viral particles, you will also receive purified pAAV_BiPVe3_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the PV+ basket cell-targeting enhancer E3. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV_BiPVe4_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213939-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV_BiCHATe27_GCaMP6f (AAV1)

    Viral Prep
    #213833-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV_BiLAMP5e3_GCaMP6f (AAV1)

    Viral Prep
    #213917-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiLAMP5e3_GCaMP6f (#213917). In addition to the viral particles, you will also receive purified pAAV_BiLAMP5e3_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the Lamp5 interneuron-targeting enhancer E3. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV_BiSSTe4_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213947-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiSSTe4_GCaMP6f (#213947). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV_BiCHATe27_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213833-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 29, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 161 - 180 of 184 results